Five policy options to remedy value-based pricing

Value-based pricing raises concerns when it comes to drug affordability. Find out more.

High-cost generic programs decrease drug spend in 5 plans

How one program moves members to less-expensive, clinically relevant alternatives. Find out more.

Conference Highlights from Industry Leaders

Pharma must adopt value-driven perspective

Joel V. Brill, MD, of Predictive Health, LLC, shares why providers and health plans aren't the only groups affected by the shift to value. Read more.

Electronic prior authorization: Lessons from BCBS

James Lang, of Blue Cross and Blue Shield of Michigan, shares how technology can improve specialty drug management. Read more.

We welcome your feedback!
Please send your comments to:

Aubrey Westgate

Executive Editor

Managed Healthcare Executive

[email protected]

DISCLAIMER:
This information has been independently developed and provided by the editors of Managed Healthcare Executive. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Industry Leader Reporters
Joel V. Brill, MD, FACP Chief Medical Officer, Predictive Health, LLC	Susan A. Cantrell, RPh, CAE Chief Executive Officer, Academy of Managed Care Pharmacy	Jennifer T. Chang, PharmD, MPH Supervisor of Regional Drug Information Services, Kaiser Permanente	James R. Lang, PharmD, MBA Vice President of Pharmacy Services, Blue Cross Blue Shield of Michigan	F. Randy Vogenberg, PhD, RPh Partner, Access Market Intelligence, LLC; cofounder, The National Institute of Collaborative Healthcare, LLC

Editorial questions? Sales questions?

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us

Key Takeaways from On-site Reporters

Five policy options to remedy value-based pricing

High-cost generic programs decrease drug spend in 5 plans

Conference Highlights from Industry Leaders

Pharma must adopt value-driven perspective

Electronic prior authorization: Lessons from BCBS

Industry Leader Reporters